Dequilla, Jesus M.
HRN: 18-20-27 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/14/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/18/2023
05/25/2023
IV
600mg
OD
Cathether Associated UTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes